Oncology nurses can support patients facing financial toxicity by offering guidance on available resources and providing ...

Ovarian cancer, historically challenging to diagnose due to vague early symptoms, often reaches advanced stages before ...

The PRECURSOR intervention appeared feasible/acceptable, suggesting a need for patient-centered conversation in incurable ...

Prostate cancer is one of the most frequently diagnosed cancers in men. Prostate tumor staging and disease aggressiveness are evaluated based on the Gleason scoring system, which is further used to ...

Explore how nanosensors are transforming cancer diagnostics by enabling earlier, more accurate, and less invasive detection ...

In this video, Robert DeBernardo, MD, shares insight on antibody-drug conjugates as treatment for patients with cancer, a topic discussed at Society of Gynecologic Oncology Annual Meeting on Women’s ...

A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.

Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.

This year, researchers Megan Shen, PhD, and Mary L. “Nora” Disis, MD, of Fred Hutch Cancer Center and UW Medicine ...

Gilead's Trodelvy and Merck's Keytruda improved progression-free survival in PD-L1+ metastatic TNBC in a Phase 3 trial with ...

This was the case for Nefa-Tari Moore, 45, a three time "thriver" of gynecological cancer. The blood test for CA-125, a commonly used marker for ovarian cancer, was never elevated for her ...